Brett Schrand

1.1k total citations · 1 hit paper
17 papers, 795 citations indexed

About

Brett Schrand is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Brett Schrand has authored 17 papers receiving a total of 795 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Immunology, 8 papers in Molecular Biology and 6 papers in Oncology. Recurrent topics in Brett Schrand's work include Immunotherapy and Immune Responses (11 papers), RNA Interference and Gene Delivery (7 papers) and Advanced biosensing and bioanalysis techniques (4 papers). Brett Schrand is often cited by papers focused on Immunotherapy and Immune Responses (11 papers), RNA Interference and Gene Delivery (7 papers) and Advanced biosensing and bioanalysis techniques (4 papers). Brett Schrand collaborates with scholars based in United States, Netherlands and Australia. Brett Schrand's co-authors include Eli Gilboa, Alexey Berezhnoy, Paloma H. Giangrande, Sarah Shigdar, Randall Brenneman, Vittorio de Franciscis, Shouhao Zhou, Amy B. Heimberger, Agata Levay and Anthony Williams and has published in prestigious journals such as Journal of Clinical Investigation, Nature Communications and Cancer Research.

In The Last Decade

Brett Schrand

17 papers receiving 783 citations

Hit Papers

Osteopontin mediates glioblastoma-associated macrophage i... 2018 2026 2020 2023 2018 50 100 150 200 250
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Osteopontin mediates glioblastoma-associated macrophage infiltration and is a potential therapeutic target
    2018 287 citations Jun Wei, Anantha Marisetty et al. Journal of Clinical Investigation profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Brett Schrand United States 12 382 291 272 158 122 17 795
Hillary G. Caruso United States 8 276 0.7× 297 1.0× 539 2.0× 234 1.5× 66 0.5× 14 813
Neha Kamran United States 15 297 0.8× 503 1.7× 307 1.1× 150 0.9× 80 0.7× 23 920
Kanako Yuki Japan 9 248 0.6× 113 0.4× 309 1.1× 133 0.8× 124 1.0× 15 629
Changlin Yang United States 13 229 0.6× 295 1.0× 263 1.0× 95 0.6× 99 0.8× 46 660
Sadhak Sengupta United States 14 278 0.7× 387 1.3× 396 1.5× 93 0.6× 83 0.7× 26 820
Federica Caponnetto Italy 12 529 1.4× 101 0.3× 109 0.4× 95 0.6× 297 2.4× 20 740
Katarzyna Franciszkiewicz France 12 352 0.9× 1.2k 4.0× 980 3.6× 156 1.0× 170 1.4× 14 1.8k
Po Y. Ho United States 7 337 0.9× 855 2.9× 391 1.4× 94 0.6× 71 0.6× 17 1.2k
Heng Wei Australia 10 493 1.3× 113 0.4× 63 0.2× 91 0.6× 317 2.6× 20 667
Carter M. Suryadevara United States 16 224 0.6× 411 1.4× 754 2.8× 292 1.8× 51 0.4× 31 1.0k

Countries citing papers authored by Brett Schrand

Since Specialization
Citations

This map shows the geographic impact of Brett Schrand's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brett Schrand with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brett Schrand more than expected).

Fields of papers citing papers by Brett Schrand

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brett Schrand. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brett Schrand. The network helps show where Brett Schrand may publish in the future.

Co-authorship network of co-authors of Brett Schrand

This figure shows the co-authorship network connecting the top 25 collaborators of Brett Schrand. A scholar is included among the top collaborators of Brett Schrand based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brett Schrand. Brett Schrand is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Ding, Jian, Brett Schrand, Holly M. Horton, et al.. (2023). Mesothelin-targeting T cells bearing a novel T cell receptor fusion construct (TRuC) exhibit potent antitumor efficacy against solid tumors. OncoImmunology. 12(1). 2182058–2182058. 25 indexed citations
2.
Shigdar, Sarah, Brett Schrand, Paloma H. Giangrande, & Vittorio de Franciscis. (2021). Aptamers: Cutting edge of cancer therapies. Molecular Therapy. 29(8). 2396–2411. 91 indexed citations
3.
Garrido, Greta, Brett Schrand, Agata Levay, et al.. (2020). Vaccination against Nonmutated Neoantigens Induced in Recurrent and Future Tumors. Cancer Immunology Research. 8(7). 856–868. 8 indexed citations
4.
Garrido, Greta, Brett Schrand, Ailem Rabasa, et al.. (2019). Tumor-targeted silencing of the peptide transporter TAP induces potent antitumor immunity. Nature Communications. 10(1). 3773–3773. 50 indexed citations
5.
Wei, Jun, Anantha Marisetty, Brett Schrand, et al.. (2018). Osteopontin mediates glioblastoma-associated macrophage infiltration and is a potential therapeutic target. Journal of Clinical Investigation. 129(1). 137–149. 287 indexed citations breakdown →
6.
Schrand, Brett, Agata Levay, Ailem Rabasa, et al.. (2018). Hapten-mediated recruitment of polyclonal antibodies to tumors engenders antitumor immunity. Nature Communications. 9(1). 3348–3348. 18 indexed citations
7.
Schrand, Brett, Agata Levay, Iris Castro, et al.. (2017). Radiation-Induced Enhancement of Antitumor T-cell Immunity by VEGF-Targeted 4-1BB Costimulation. Cancer Research. 77(6). 1310–1321. 30 indexed citations
8.
Rajagopalan, Anugraha, et al.. (2017). Aptamer-Targeted Attenuation of IL-2 Signaling in CD8 + T Cells Enhances Antitumor Immunity. Molecular Therapy. 25(1). 54–61. 41 indexed citations
9.
Gefen, Tal, et al.. (2017). Potentiating tumor immunity using aptamer-targeted RNAi to render CD8 + T cells resistant to TGFβ inhibition. OncoImmunology. 7(4). e1349588–e1349588. 11 indexed citations
10.
Benaduce, Ana Paula, Randall Brenneman, Brett Schrand, et al.. (2016). 4-1BB Aptamer-Based Immunomodulation Enhances the Therapeutic Index of Radiation Therapy in Murine Tumor Models. International Journal of Radiation Oncology*Biology*Physics. 96(2). 458–461. 13 indexed citations
11.
Schrand, Brett, Ana Paula Benaduce, Eli Gilboa, & Adrian Ishkanian. (2016). Radiation-Induced Tumor Targeting of Immunomodulatory Aptamers Induces Abscopal Response and Tumor Control in Murine Models of Breast Cancer. International Journal of Radiation Oncology*Biology*Physics. 96(2). S127–S127. 1 indexed citations
12.
Schrand, Brett, Alexey Berezhnoy, Randall Brenneman, et al.. (2015). Reducing toxicity of 4–1BB costimulation: targeting 4–1BB ligands to the tumor stroma with bi-specific aptamer conjugates. OncoImmunology. 4(3). e970918–e970918. 18 indexed citations
13.
Kong, Ling-Yuan, Jun Wei, Gregory N. Fuller, et al.. (2015). Tipping a favorable CNS intratumoral immune response using immune stimulation combined with inhibition of tumor-mediated immune suppression. OncoImmunology. 5(5). e1117739–e1117739. 6 indexed citations
14.
Gilboa, Eli, Alexey Berezhnoy, & Brett Schrand. (2015). Reducing Toxicity of Immune Therapy Using Aptamer-Targeted Drug Delivery. Cancer Immunology Research. 3(11). 1195–1200. 32 indexed citations
15.
Schrand, Brett, Alexey Berezhnoy, Randall Brenneman, et al.. (2014). Targeting 4-1BB Costimulation to the Tumor Stroma with Bispecific Aptamer Conjugates Enhances the Therapeutic Index of Tumor Immunotherapy. Cancer Immunology Research. 2(9). 867–877. 72 indexed citations
16.
Hao, Sijie, Anthony Williams, Ramdane Harouaka, et al.. (2014). Separable Bilayer Microfiltration Device for Viable Label-free Enrichment of Circulating Tumour Cells. Scientific Reports. 4(1). 7392–7392. 89 indexed citations
17.
Schrand, Brett, et al.. (2011). Nestling Sex Ratios in Two Populations of Northern Mockingbirds. Southeastern Naturalist. 10(2). 365–370. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hillary G. Caruso Breakdown of academic impact, for papers by Neha Kamran Breakdown of academic impact, for papers by Kanako Yuki Breakdown of academic impact, for papers by Changlin Yang Breakdown of academic impact, for papers by Sadhak Sengupta Breakdown of academic impact, for papers by Federica Caponnetto Breakdown of academic impact, for papers by Katarzyna Franciszkiewicz Breakdown of academic impact, for papers by Po Y. Ho Breakdown of academic impact, for papers by Heng Wei Breakdown of academic impact, for papers by Carter M. Suryadevara
Rankless by CCL
2026